
|Videos|November 19, 2020
Long-Acting Injectable Antipsychotics in the Era of COVID-19
Author(s)Frank Chen, MD
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.
Advertisement
The training wheels on telepsychiatry have been yanked off. Where it was once an exception, telepsychiatry is the new norm. But how does this impact the patients who need more intense care?
Frank Chen, MD, explains.
Dr Chen is Chief Medical Officer at Houston Behavioral Healthcare Hospital.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Future DSM Plans Overlook Core Problem of Validity
3
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
4
Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy
5









